Companies: 10,795·Total market cap: $144.5T
Britannia Life Sciences Inc.

Britannia Life Sciences Inc.

BLAB.CNCNQHealthcare● Active
$0.09
+$0.00(+0.00%)
Market Cap$13791619
P/E Ratio
52W High$0.14
52W Low$0.06

Britannia Life Sciences Inc. (BLAB.CN) Revenue

Annual & quarterly revenue history · segment & region breakdown

BLAB.CN · revenue · updated Jun 10, 2026

Core revenue metrics

Britannia Life Sciences Inc. trailing twelve-month (TTM) revenue is $-0.00B, an increase of 0.00% year-over-year from — in FY.

TTM revenue
$-0.00B
4-quarter sum · USD
YoY growth
+0.00%
vs FY
Price / sales
mktCap ÷ TTM rev
Revenue per day
Est. TTM ÷ 365
Revenue / employee
$-155K
28 employees
FY
FY
5Y CAGR
Fiscal year end
Dec 31
Currency
USD · GAAP
Filing
10-K / 10-Q
Source: FMP · Britannia Life Sciences Inc. SEC filings · GAAPUpdated: 2026-06-10

Revenue trend

· Annual
YoY revenue growth %
revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year endRevenueChangeGrowth
BLAB.CN revenue by year · BLAB.CN revenue history · BLAB.CN annual revenue data

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income Britannia Life Sciences Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

Britannia Life Sciences Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.

Data sourced from Britannia Life Sciences Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Frequently asked questions

BLAB.CN revenue · 4 questions

BLAB.CN's trailing twelve-month (TTM) revenue is $-0.00B. That is an increase of 0.00% year-over-year from — in FY.

BLAB.CN revenueBLAB.CN annual revenuewhat is BLAB.CN revenueBLAB.CN TTM revenue

Source: FMP · Britannia Life Sciences Inc. SEC filings · GAAP · Britannia Life Sciences Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 10, 2026